Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
57.211,75
-1,76%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ MiMedx Group Inc (MDXG) MiMedx Group Inc (MDXG) Notizie

MiMedx Group Inc

MDXG
7,25
1,09 (17,69%)
02 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/4/202422:01GLOBEMIMEDX Announces First Quarter 2024 Operating and Financial..
16/4/202414:00GLOBEMIMEDX to Host First Quarter 2024 Operating and Financial..
27/3/202413:00GLOBEMIMEDX Provides Update on AXIOFILL® Request for Designation..
20/3/202412:00GLOBEMIMEDX Expands Portfolio with Fibrillar Collagen Wound..
13/3/202413:00GLOBEMIMEDX Introduces E-Commerce and Account Management Platform
06/3/202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202400:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202400:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202414:11EDGAR2Form 8-K - Current report
04/3/202414:00GLOBEMIMEDX Announces Appointment of Two New Independent..
28/2/202422:22EDGAR2Form 8-K - Current report
28/2/202422:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202422:01GLOBEMIMEDX Announces Fourth Quarter and Full Year 2023 Operating..
21/2/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202421:55EDGAR2Form 144 - Report of proposed sale of securities
20/2/202414:00GLOBEMIMEDX to Present at TD Cowen 44th Annual Health Care..
16/2/202422:37EDGAR2Form 144 - Report of proposed sale of securities
16/2/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202421:11EDGAR2Form 144 - Report of proposed sale of securities
14/2/202422:13EDGAR2Form 144 - Report of proposed sale of securities
12/2/202414:00GLOBEMIMEDX to Host Fourth Quarter and Full Year 2023 Operating..
22/1/202414:09EDGAR2Form 8-K - Current report
22/1/202414:00GLOBEMIMEDX Announces Improved Capital Structure with New Senior..
29/12/202323:00GLOBEMIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year..
28/12/202322:30EDGAR2Form 8-K - Current report
28/12/202314:00GLOBEMIMEDX Announces Conversion of Outstanding Series B..
27/12/202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202322:42EDGAR2Form SC 13D/A - General statement of acquisition of..
22/11/202323:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202314:14EDGAR2Form 8-K - Current report
13/11/202314:00GLOBEMIMEDX to Participate in Upcoming Investor Conferences
02/11/202313:00GLOBEMIMEDX to Highlight Published Data at SAWC Fall
30/10/202321:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/10/202321:05EDGAR2Form 8-K - Current report
30/10/202321:01GLOBEMIMEDX Announces Third Quarter 2023 Operating and Financial..
16/10/202314:00GLOBEMIMEDX to Host Third Quarter 2023 Operating and Financial..
26/9/202314:00GLOBEMIMEDX Announces Launch of EPIEFFECT™
05/9/202323:00EDGAR2Form 8-K - Current report
05/9/202314:38EDGAR2Form 8-K - Current report
05/9/202314:00GLOBEMIMEDX to Present at Upcoming Investor Conferences
01/8/202322:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202322:03EDGAR2Form 8-K - Current report
01/8/202322:01GLOBEMIMEDX Announces Second Quarter 2023 Operating and Financial..
25/7/202322:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
25/7/202322:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
18/7/202314:00GLOBEMIMEDX to Host Second Quarter 2023 Operating and Financial..
11/7/202314:30GLOBEMIMEDX Announces Favorable Ruling in Putative Securities..
07/7/202300:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/7/202300:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/7/202315:02EDGAR2Form 8-K - Current report
Apertura: 6,46 Min: 6,33 Max: 7,40
Chiusura: 6,16

La tua Cronologia

NASDAQ
MDXG
MiMedx
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network